CR Bard Pays $48M To Settle FCA, Kickback Claims

Law360, Washington (May 13, 2013, 7:53 PM EDT) -- C.R. Bard Inc. will hand over approximately $48.3 million to the federal government to settle whistleblower allegations that it filed false Medicare claims and paid hospitals various kickbacks to use its brachytherapy seeds for prostate cancer treatment, the U.S. Department of Justice announced Monday.

According to the DOJ, Bard gave hospitals grants, guaranteed minimum rebates, marketing assistance, free medical equipment and conference fees to entice them to use the radiation therapy seeds from 1998 to 2006. As the hospitals also submitted bills to Medicare for the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.